| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4875342aba2f84fb0d2c84720827ed72 |
| publicationDate |
2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2936256-A1 |
| titleOfInvention |
MODULATORS OF LGR5 IN THE TREATMENT OF ALOPECIA |
| abstract |
The invention relates to an in vitro method for screening candidate compounds for the preventive or curative treatment of alopecia, comprising determining the ability of a compound to modulate the expression or activity of the LGR5 receptor, as well as the use of modulators of the expression or activity of this receptor for the treatment of alopecia. The invention also relates to methods for in vitro diagnosis or prognosis of this pathology. |
| priorityDate |
2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |